Log in  First Connection?

DialysisArchives

Cefuroxime concentrations in facial artery musculomucosal flap, buccal submucosa, subcutaneous tissue, and plasma following bolus or continuous infusion in patients undergoing oral cancer resection: a randomized clinical microdialysis study
Dialysis
 1 min.

 Published on 25/03/2026 |  Original article (Full-text)  | Johanne Ravn Hansen et al. | Journal of Antimicrobial Chemotherapy. Volume 81(4).

Perioperative antibiotic prophylaxis is essential in oral cancer surgery to prevent surgical site infections, particularly when regional flaps such as the facial artery musculomucosal (FAMM) flap are used. This study compared free cefuroxime concentrations in plasma, FAMM flap, buccal submucosa and subcutaneous...

Imaging features of azygos vein migration of haemodialysis catheter and repositioning using the modified loop-snare technique
Dialysis
 2 min.

 Published on 18/03/2026 |  Original article (Full-text)  | Chun Kei Boris Chow et al. | BMJ case reports 2026; 19(1): e267923

Approximately 850 million people worldwide have chronic kidney disease (CKD). Over the past three decades, CKD incidence, mortality and disability-adjusted life years have increased significantly,1 primarily due to an ageing population, establishing CKD as a global healthcare burden. Renal transplantation...

Hygiene behaviours and protective attitudes in haemodialysis patients during COVID-19: impact on quality of life
Dialysis
 6 min.

 Published on 11/03/2026 |  Original article (Full-text)  | Bicakci Sukran et al. | BMC Nephrology 2026; 27(1): 148

The novel coronavirus, which first emerged in China in December 2019, spread rapidly around the world, posing a global threat to public health [1, 2]. The severity of the disease, its lethality, and its impact on vulnerable groups have frightened the entire world, bringing protective measures to the...

Hemodialysis versus peritoneal dialysis in elderly ESRD patients: a retrospective cohort study on survival and the role of comorbidities
Dialysis
 6 min.

 Published on 04/03/2026 |  Original article (Full-text)  | Yu Ruizhi et al. | BMC Nephrology 2026; 27(1): 142

Against the backdrop of accelerating global population aging, the incidence of ESRD continues to rise.In China, this trend is particularly pronounced: the proportion of individuals aged ≥ 60 years rose from 7.54% in 1982 to 21.07% in 2023, and those aged ≥ 65 years increased from 4.91% to 15.38%...

The relationship between sleep quality, fatigue, and depressive symptoms in maintenance hemodialysis patients: a cross-lagged analysis
Dialysis
 6 min.

 Published on 25/02/2026 |  Original article (Full-text)  | Tan Hong et al. | BMC Nephrology 2026; 27(1): 139

Maintenance hemodialysis (MHD) is the primary treatment for patients with end-stage renal disease (ESRD), accounting for approximately 90% of all dialysis worldwide [1]. As of December 2022, the number of individuals undergoing dialysis in China had exceeded one million [2]. Although MHD effectively...